Artelo Biosciences Q2 EPS $(0.89) Up From $(16.83) YoY

Benzinga Newsdesk www.benzinga.com Negative 74.8%

Neg 74.8% Neu 0% Pos 0%

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.89) per share. This is a 94.71 percent increase over losses of $(16.83) per share from the same period last year.